logo
episode-header-image
Feb 2023
15 m

Episode 11: Recent Progress in the Treat...

KDIGO Communications
About this episode
tail spinning
Up next
May 27
Episode 33: Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
In the third episode of the KDIGO Conversations in Nephrology FSGS series, host Dr. Kirk Campbell (University of Pennsylvania) sits down with world-renowned glomerular disease expert Dr. Jai Radhakrishnan (Columbia University) to navigate the shifting landscape of Focal Segmental ... Show More
11m 45s
May 27
Episode 32: Proteinuria First: Managing What Matters in FSGS
In this second episode of the three-part KDIGO Conversations in Nephrology series, Dr. Kirk Campbell speaks with Dr. Laura Mariani about the central role of proteinuria reduction in the management of focal segmental glomerulosclerosis (FSGS). The discussion explores the biologic ... Show More
13m 30s
May 27
Episode 31: The Podocyte Problem: Understanding FSGS
Join Dr. Kirk Campbell (University of Pennsylvania) and Dr. Alessia Fornoni (University of Miami) for an in-depth conversation on the evolving landscape of Focal Segmental Glomerulosclerosis (FSGS). The first episode of this three-part FSGS series explores the transition from tra ... Show More
14m 45s
Recommended Episodes
Jan 2023
ImmunoTea Episode 1 - IL-17 and Neurological Autoimmunity
On this episode Lara and Vyanka talk to Prof Kingston Mills and Dr Anastasia Zekeridou all about IL-17 and and neurological autoimmunity. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about ... Show More
50m 30s
Jan 2022
OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
Join host Dr. Paul Whiting as he interviews paper authors Drs. Hassan Mir and Mitchell John as they discuss the Notable Paper on treatment of venous thromboembolism. This paper was presented at the OTA 2021 Annual Meeting. For additional educational resources visit https://ota.or ... Show More
10m 59s
Feb 2023
184. Backed Up - An Approach to SVC Syndrome
Send us Fan MailIn this episode, we discuss the approach to a patient with SVC syndrome. This includes considering both malignant and non-malignant causes. Treatment focuses on relief of the obstruction and investigation and management of malignant causes. Our medicine minute dis ... Show More
14m 4s
Apr 2020
The search for a remedy
As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ... Show More
20m 17s
Jun 2024
Comparing IV Thrombolysis to Endovascular Therapy in Basilar Occlusion
Dr. Dan Ackerman talks with Dr. Silja Räty about the outcomes of patients with basilar artery occlusion treated with intravenous thrombolysis (IVT) only and compares IVT with endovascular thrombectomy. Read the related article in Neurology. This podcast is sponsored by argenx. Vi ... Show More
18m 19s
Feb 2009
TWiV #22 - Viral bioinformatics
tail spinning
59m 2s
Oct 2022
Cardiacast: Treatment for Amyloidosis Including Evidence-Based Therapies, Pitfalls, and Advanced Heart Failure Management
In this episode Richard Cheng MD and Michelle Kittleson MD discuss treatment for amyloidosis, including evidence-based therapies, pitfalls, and advanced heart failure management. This podcast is part of the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment grant initiativ ... Show More
18m 19s
Jan 2025
2025 Retina Update, Part 1: Injectables in the Medical Retina Space
Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related ... Show More
43m 39s
Jun 2022
152. Going Out on a Limb - An Approach to Peripheral Arterial Disease
Send us Fan MailIn this episode, we discuss the clinical manifestations, diagnosis and management of peripheral arterial disease. Our medicine minute focuses on emerging evidence for the use of Rivaroxaban following the release of the COMPASS trial in 2020. Written by: Dr. Palki ... Show More
12m 29s
Jul 2024
Season 4 Episode 7: Changing Treatment Landscape in IgAN and Disease Modification Approaches (supported by Vera Therapeutics)
For this episode of the Global Kidney Care Podcast, Jonathan Barratt, MD, MSc, PhD is Professor of Renal Medicine, Department of Cardiovascular Sciences at the University of Leicester and Richard Lafayette, MD, FACP is a Nephrologist and Professor of Medicine at the Division of N ... Show More
25m 13s
Listen to millions of songs and podcasts on Anghami